IRONWOOD PHARMACEUTICALS, INC.
IRWD · NASDAQ
Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Market Data
Price
$4.29
+0.15 (+3.62%)
Market Cap$687M
P/E Ratio6.72
EPS$—
52W High$5.78
52W Low$1.01
Beta0.21
Data from Finnhub · Updated Aug 24, 2026